The cardiovascular effects of AH 8165. A new non-depolarizing muscle relaxant.
D000293:Adolescent; D000328:Adult; D000768:Anesthesia, General; D001391:Azo Compounds / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002496:Central Venous Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D012121:Respiration, Artificial; D014655:Vascular Resistance / Q000187:drug effects
D001391:Azo Compounds; D007093:Imidazoles; D003473:Neuromuscular Nondepolarizing Agents; D011726:Pyridinium Compounds; D002245:Carbon Dioxide